Robert Brookland, MD
Radiation Oncology · Towson, MDNPI 1548261647
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Bayer accounts for 92.1% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2020 at $9,487 and has fallen 89.2% since, to $1,027 in 2025. Among radiation oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $214.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$31K
- Novartis$349
- Boston Scientific$327
- Progenics Pharmaceuticals, Inc.$178
- Sumitomo Pharma America, Inc.$159
- Teleflex LLC$139
- plus $2K from 23 others
Across 104 payments — averaging $933.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$90K
- Bayer$7K
What the payments were for
- Consulting fees$11,99436%
- Speaking & faculty fees$16,04448%
- Travel & lodging$7512%
- Food & beverage$4,95715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 77 | $31,071 |
| Novartis | 10 | $349 |
| Boston Scientific | 6 | $327 |
| Progenics Pharmaceuticals, Inc. | 4 | $178 |
| Sumitomo Pharma America, Inc. | 6 | $159 |
| Teleflex LLC | 1 | $139 |
| Immunitybio, Inc. | 1 | $135 |
| Merck | 7 | $133 |
| Myovant Sciences Inc. | 5 | $124 |
| AbbVie | 4 | $114 |
| Dendreon Pharmaceuticals LLC | 4 | $99 |
| Accord Healthcare, Inc. | 1 | $98 |
| Medtronic | 1 | $95 |
| Myriad Genetic Laboratories, Inc. | 4 | $88 |
| Palette Life Sciences, Inc. | 3 | $81 |
| Astellas Pharma US Inc | 4 | $80 |
| Urogen Pharma, Inc. | 1 | $76 |
| Telix Pharmaceuticals | 2 | $73 |
| Pfizer | 3 | $53 |
| Bioprotect Medical, Inc. | 2 | $48 |
| Siemens Medical Solutions USA, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Reflexion Medical, Inc. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
| Exelixis Inc. | 1 | $27 |
| Elekta, Inc. | 2 | $25 |
| 180 Medical, Inc. | 1 | $18 |
| Blue Earth Diagnostics | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,747 in reported general payments places this provider in the 95th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 138 | $1,900 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Towson
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- John MansuetiBerlin$11K
- Avani RaoBaltimore$10K
- Lawrence ShombertCumberland$9K
- Amanda WalkerBaltimore$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.